Showing 1 - 10 of 12
Persistent link: https://www.econbiz.de/10008873538
Persistent link: https://www.econbiz.de/10012020069
Persistent link: https://www.econbiz.de/10011294610
Persistent link: https://www.econbiz.de/10011772984
Persistent link: https://www.econbiz.de/10010030048
Persistent link: https://www.econbiz.de/10009616664
Precision medicines inherently fragment treatment populations, generating small-population markets, creating high-priced "niche busters" rather than broadly prescribed "blockbusters". It is plausible to expect that small markets will attract limited entry in which a small number of...
Persistent link: https://www.econbiz.de/10012453693
Precision medicines inherently fragment treatment populations, generating small-population markets, creating high-priced "niche busters" rather than broadly prescribed "blockbusters". It is plausible to expect that small markets will attract limited entry in which a small number of...
Persistent link: https://www.econbiz.de/10012943199
The economics of stratified medicine depend critically on setting the cut-off score of the companion diagnostic (CDx). This action integrates scientific, clinical, ethical and commercial considerations, and simultaneously determines the value of the stratified medicine to developers, providers,...
Persistent link: https://www.econbiz.de/10013021484
The economics of stratified medicine depend critically on setting the cut-off score of the companion diagnostic (CDx). This action integrates scientific, clinical, ethical and commercial considerations, and simultaneously determines the value of the stratified medicine to developers, providers,...
Persistent link: https://www.econbiz.de/10012457434